cerrar
Tagged with BIA

3 Pfizer Country Managers on COVID-19 Vaccine Rollout &…
The global push to vaccinate populations against COVID-19 has played out differently in different geographies, with a yawning gap still existing…

Frederico Silva – General Manager, Gilead Sciences Middle…
Frederico Silva outlines the highlights of his two years heading up Gilead Sciences' relatively young Middle-East affiliate, how Gilead has pivoted to…

Ahmed Alaskar – Executive Director, KAIMRC, Saudi Arabia
Dr Ahmed Alaskar is executive director of the King Abdullah International Medical Research Center (KAIMRC); president of the Saudi Society of Blood…

Zeina Sfeir Lahoud – GM, Biologix
Biologix is a Dubai-based firm that represents international pharma companies by bringing innovative drugs to market in the Middle East / North Africa…

László Svinger – VP & MD, 3M Middle East &…
3M, an American multinational conglomerate, has been in the limelight since the beginning of the COVID-19 pandemic primarily as one of the leading…

Three Key Trends to Watch in Saudi Arabia’s Pharma Industry
Looking to diversify its economy while simultaneously improving its healthcare system, Saudi Arabia has been rolling out incentives for international…

Mohammed Al-Tawil – Regional Managing Director & Head…
Boehringer Ingelheim’s Regional Managing Director and Head of Human Pharma in the Middle East, Turkey, and Africa (‘META’) Mohammed Al-Tawil…

Top 2021 Insights from Global Regulators
Over the past 12 months, PharmaBoardroom has spoken to the heads of several key regulatory bodies across the world. While the approval processes for…

Trad Alkhelaiwi – Country Director, Amgen Saudi Limited
Trad Alkhelaiwi, country director for Amgen in Saudi Arabia, discusses the intricacies of the Saudi healthcare transformation including the push for a…

PharmaBoardroom’s Top 10 Most Read Interviews of 2021 (So Far)
PharmaBoardroom has spread its wings far and wide in 2021 (albeit digitally!), from well covered markets such as Singapore and Switzerland to new…

Pharma Faces: Dimitri Livadas, Lilly Saudi Arabia
Having commenced his journey with American giant Lilly in 2008, and after almost eight years working in the company’s Japan organization, mostly on…

Saudi Arabia: Significant Steps Towards Clinical Trial Hub Status
Clinical trials provide a pathway to innovation for clinicians and patients in countries like Saudi Arabia and form a key element of the country’s…
We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here